Mumbai, India has emerged as a vital hub for the production of Acalabrutinib Active Pharmaceutical Ingredient (API), with several companies focused on its synthesis . Notably, certain manufacturers in this region are recognized for their high-quality Acalabrutinib (CAS 1420477-60-6) production, providing a reliable source for pharmaceutical compani